ABSTRACT
Few data exist that highlight areas where telemedicine shines or struggles from the patient perspective. We conducted a retrospective analysis of patient experience data from 19,465 visits using a logistic regression to model the odds a virtual visit addressed a patient's medical needs. Patient age (80 years: OR 0.58; 95% CI, 0.50-0.67 vs 40-64 years), race (Black: 0.68; 95% CI, 0.60-0.76 vs White), and connection (telephone conversion: OR 0.59; 95% CI, 0.53-0.66 vs video success) were associated with a lower likelihood of addressing medical needs; results varied modestly across specialties. These data suggest that while telehealth is generally well accepted by patients, differences are seen among patient factors and specialty.
Subject(s)
Telemedicine , Humans , Aged, 80 and over , Cross-Sectional Studies , Retrospective StudiesABSTRACT
BACKGROUND: Intestinal failure-associated liver disease (IFALD) is one of the leading complications in type III intestinal failure (IF). Early recognition of liver-fibrosis development in IFALD is crucial to the development of strategies aimed at reducing the risk of complications secondary to IFALD. Our aim was to identify patients with advanced fibrosis using a noninvasive index and to study the risk factors for fibrosis development in the Sustain registry. METHODS: Using the Sustain registry, patients requiring >3 months of parenteral nutrition (PN) support were identified. The presence or absence of advanced fibrosis was identified using the Fibrosis-4 (FIB-4) index. Risk factors for the presence of a high FIB-4 score were identified using univariable logistic regression. RESULTS: Two hundred seventy-one adult patients were included. Sixty-three patients (23.2%) were at risk for advanced fibrosis based on the FIB4-index. Risk factors for advanced fibrosis included short-bowel syndrome (odds ratios [ORs]: 1.84; 95% confidence interval [CI], 1.03-3.28), receipt of PN for >1 year (OR: 2.6; 95% CI, 1.46-4.64), receipt of PN for >5 years (OR: 3.05; 95% CI, 1.67-5.59), and days of lipid emulsion use (OR: 1.11; 95% CI, 1-1.24). Small-intestine-remnant length was inversely associated with advanced fibrosis (OR: 0.97, 95% CI, 0.95-0.99). CONCLUSION: Advanced fibrosis, as guided by FIB-4 index, is associated with known risk factors for IFALD. Therefore, the FIB-4 index is potentially a useful noninvasive tool for identification of individuals at risk for fibrosis in IFALD. Further studies utilizing a gold-standard fibrosis assessment will be required to validate these results.